Cormorant Asset Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,116,949
| Closed | -$16.3M | – | 72 |
|
|
2023
Q1 | $16.3M | Hold |
4,116,949
| – | – | 1.07% | 26 |
|
|
2022
Q4 | $29.8M | Hold |
4,116,949
| – | – | 2% | 15 |
|
|
2022
Q3 | $14.9M | Sell |
4,116,949
-390,894
| -9% | -$1.42M | 1.04% | 33 |
|
|
2022
Q2 | $20.4M | Sell |
4,507,843
-391,342
| -8% | -$1.77M | 1.54% | 22 |
|
|
2022
Q1 | $37.1M | Hold |
4,899,185
| – | – | 2.85% | 12 |
|
|
2021
Q4 | $53.1M | Buy |
4,899,185
+1,000,000
| +26% | +$10.8M | 3.16% | 9 |
|
|
2021
Q3 | $48.8M | Buy |
3,899,185
+3,099,185
| +387% | +$38.8M | 1.98% | 15 |
|
|
2021
Q2 | $9.1M | Hold |
800,000
| – | – | 0.31% | 62 |
|
|
2021
Q1 | $8.9M | Hold |
800,000
| – | – | 0.2% | 72 |
|
|
2020
Q4 | $9.15M | Hold |
800,000
| – | – | 0.22% | 63 |
|
|
2020
Q3 | $8.37M | Buy |
+800,000
| New | +$8.37M | 0.32% | 59 |
|